EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Cell-free DNA approaches for cancer early detection and interception

Jamie E Medina iD, Nicholas C Dracopoli, Peter B Bach, Anna Lau, Robert B Scharpf, Gerrit A Meijer, Claus Lindbjerg Andersen, Victor E Velculescu iD

Journal for ImmunoTherapy of Cancer · 2023-09 · 11 (9) · e006013

DOI: 10.1136/jitc-2022-006013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 11.09.2023. Verfasst von Jamie E Medina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Neoplasms. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Commonwealth Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid advancements in the area of early cancer detection have brought us closer to achieving the goals of finding cancer early enough to treat or cure it, while avoiding harms of overdiagnosis. We evaluate progress in the development of early cancer detection tests in the context of the current principles for cancer screening. We review cell-free DNA (cfDNA)-based approaches using mutations, methylation, or fragmentomes for early cancer detection. Lastly, we discuss the challenges in demonstrating clinical utility of these tests before integration into routine clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsNeoplasmsHumansEarly Detection of CancerMutation

Stichwörter der Autor:innen

Biomarkers, TumorNeoplastic Cells, CirculatingReview

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Delfi Diagnostics Inc, Baltimore, Maryland, USA.
  • Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA velculescu@jhmi.edu.

ORCID-Profile: Jamie E Medina, Victor E Velculescu

Förderung

  • NCI NIH HHS
  • Commonwealth Foundation
  • National Institutes of Health
  • SU2C InTime Lung Cancer Interception Dream Team
  • Gray Foundation
  • Stand Up to Cancer-Dutch Cancer Society International Translational Cancer Research Dream Team
  • Tina’s Wish Foundation
  • Cole Foundation

Zitieren

APA

Medina, J. E., Dracopoli, N. C., Bach, P. B., Lau, A., Scharpf, R. B., Meijer, G. A., Andersen, C. L., & Velculescu, V. E. (2023). Cell-free DNA approaches for cancer early detection and interception. Journal for ImmunoTherapy of Cancer, 11(9), e006013. https://doi.org/10.1136/jitc-2022-006013

Vancouver

Medina JE, Dracopoli NC, Bach PB, Lau A, Scharpf RB, Meijer GA, et al. Cell-free DNA approaches for cancer early detection and interception. Journal for ImmunoTherapy of Cancer. 2023;11(9):e006013. doi:10.1136/jitc-2022-006013

BibTeX
@article{Medina2023,
  author = {Medina, Jamie E and Dracopoli, Nicholas C and Bach, Peter B and Lau, Anna and Scharpf, Robert B and Meijer, Gerrit A and Andersen, Claus Lindbjerg and Velculescu, Victor E},
  title = {Cell-free DNA approaches for cancer early detection and interception},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  volume = {11},
  number = {9},
  pages = {e006013},
  doi = {10.1136/jitc-2022-006013}
}
Kostenlos starten →